Astrana Health Stock Market Value
| ASTH Stock | 22.74 0.33 1.47% |
| Symbol | Astrana |
Is there potential for Health Care Providers & Services market expansion? Will Astrana introduce new products? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.98) | Earnings Share 0.19 | Revenue Per Share | Quarterly Revenue Growth 0.997 | Return On Assets |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Astrana Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Astrana Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Astrana Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Astrana Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Astrana Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Astrana Health.
| 11/02/2025 |
| 01/31/2026 |
If you would invest 0.00 in Astrana Health on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding Astrana Health or generate 0.0% return on investment in Astrana Health over 90 days. Astrana Health is related to or competes with Select Medical, Mednax, National HealthCare, Aveanna Healthcare, Acadia Healthcare, US Physicalrapy, and MannKind Corp. Astrana Health is entity of United States More
Astrana Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Astrana Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Astrana Health upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 31.71 | |||
| Value At Risk | (7.67) | |||
| Potential Upside | 6.14 |
Astrana Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Astrana Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Astrana Health's standard deviation. In reality, there are many statistical measures that can use Astrana Health historical prices to predict the future Astrana Health's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.51) | |||
| Total Risk Alpha | (0.68) | |||
| Treynor Ratio | (0.16) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Astrana Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Astrana Health January 31, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.15) | |||
| Mean Deviation | 3.33 | |||
| Coefficient Of Variation | (1,311) | |||
| Standard Deviation | 5.37 | |||
| Variance | 28.85 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.51) | |||
| Total Risk Alpha | (0.68) | |||
| Treynor Ratio | (0.16) | |||
| Maximum Drawdown | 31.71 | |||
| Value At Risk | (7.67) | |||
| Potential Upside | 6.14 | |||
| Skewness | (2.08) | |||
| Kurtosis | 7.44 |
Astrana Health Backtested Returns
Astrana Health secures Sharpe Ratio (or Efficiency) of -0.0805, which signifies that the company had a -0.0805 % return per unit of risk over the last 3 months. Astrana Health exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Astrana Health's Mean Deviation of 3.33, standard deviation of 5.37, and Risk Adjusted Performance of (0.05) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.65, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Astrana Health will likely underperform. At this point, Astrana Health has a negative expected return of -0.44%. Please make sure to confirm Astrana Health's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Astrana Health performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.39 |
Poor reverse predictability
Astrana Health has poor reverse predictability. Overlapping area represents the amount of predictability between Astrana Health time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Astrana Health price movement. The serial correlation of -0.39 indicates that just about 39.0% of current Astrana Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.39 | |
| Spearman Rank Test | -0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 4.54 |
Currently Active Assets on Macroaxis
When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:Check out Astrana Health Correlation, Astrana Health Volatility and Astrana Health Performance module to complement your research on Astrana Health. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Astrana Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.